{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:53:14Z","timestamp":1770367994969,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00270-013-0654-7","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T22:10:02Z","timestamp":1370902202000},"page":"381-387","source":"Crossref","is-referenced-by-count":57,"title":["Safety and Effectiveness of Chemoembolization with Drug-Eluting Beads for Advanced-Stage Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Sanjeeva P.","family":"Kalva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Pectasides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan","family":"Rachamreddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shravani","family":"Surakanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpana","family":"Yeddula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvranu","family":"Ganguli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Wicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence S.","family":"Blaszkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"key":"654_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"654_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00001574-200305000-00007","volume":"19","author":"JA Marrero","year":"2003","unstructured":"Marrero JA (2003) Hepatocellular carcinoma. Curr Opin Gastroenterol 19:243\u2013249","journal-title":"Curr Opin Gastroenterol"},{"key":"654_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","volume":"30","author":"A Forner","year":"2010","unstructured":"Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30:61\u201374","journal-title":"Semin Liver Dis"},{"key":"654_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","volume":"40","author":"JM Llovet","year":"2005","unstructured":"Llovet JM (2005) Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 40:225\u2013235","journal-title":"J Gastroenterol"},{"key":"654_CR5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J Bruix","year":"2005","unstructured":"Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208\u20131236","journal-title":"Hepatology"},{"key":"654_CR6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020\u20131022","journal-title":"Hepatology"},{"key":"654_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"key":"654_CR8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"654_CR9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1470-2045(09)70171-8","volume":"10","author":"S Faivre","year":"2009","unstructured":"Faivre S, Raymond E, Boucher E et al (2009) Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. Lancet Oncol 10:794\u2013800","journal-title":"Lancet Oncol"},{"key":"654_CR10","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Monta\u00f1a X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"654_CR11","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164\u20131171","journal-title":"Hepatology"},{"key":"654_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","volume":"224","author":"C Camm\u00e0","year":"2002","unstructured":"Camm\u00e0 C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47\u201354","journal-title":"Radiology"},{"key":"654_CR13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1148\/radiographics.18.3.9599386","volume":"18","author":"I Sakamoto","year":"1998","unstructured":"Sakamoto I, Aso N, Nagaoki K et al (1998) Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 18:605\u2013619","journal-title":"Radiographics"},{"key":"654_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1148\/radiology.198.1.8539401","volume":"198","author":"JW Chung","year":"1996","unstructured":"Chung JW, Park JH, Han JK et al (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198:33\u201340","journal-title":"Radiology"},{"key":"654_CR15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1051-0443(99)70117-X","volume":"10","author":"B Solomon","year":"1999","unstructured":"Solomon B, Soulen MC, Baum RA et al (1999) Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a US population. J Vasc Interv Radiol 10:793\u2013798","journal-title":"J Vasc Interv Radiol"},{"key":"654_CR16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00270-010-0044-3","volume":"34","author":"K Malagari","year":"2011","unstructured":"Malagari K, Pomoni M, Spyridopoulos TN et al (2011) Safety profile of sequential transcatheter chemoembolization with DC Bead\u2122: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol 34:774\u2013785","journal-title":"Cardiovasc Intervent Radiol"},{"key":"654_CR17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00261-007-9334-x","volume":"33","author":"K Malagari","year":"2008","unstructured":"Malagari K, Alexopoulou E, Chatzimichail K et al (2008) Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging 33:512\u2013519","journal-title":"Abdom Imaging"},{"key":"654_CR18","first-page":"820","volume":"59","author":"M Pomoni","year":"2012","unstructured":"Pomoni M, Malagari K, Moschouris H et al (2012) Postembolization syndrome in doxorubicin eluting chemoembolization with DC Bead. Hepatogastroenterology 59:820\u2013825","journal-title":"Hepatogastroenterology"},{"key":"654_CR19","doi-asserted-by":"crossref","first-page":"W562","DOI":"10.2214\/AJR.10.4379","volume":"197","author":"TJ Vogl","year":"2011","unstructured":"Vogl TJ, Lammer J, Lencioni R et al (2011) Liver, gastrointestinal, and cardiac toxicity in intermediate hepatocellular carcinoma treated with PRECISION TACE with drug-eluting beads: results from the PRECISION V randomized trial. Am J Roentgenol 197:W562\u2013W570","journal-title":"Am J Roentgenol"},{"key":"654_CR20","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/MCG.0b013e31820fb274","volume":"45","author":"BI Carr","year":"2011","unstructured":"Carr BI, Bron K, Swanson DP (2011) Prospective randomized trial of hepatic artery chemotherapy with cisplatin and doxorubicin, with or without lipiodol in the treatment of advanced stage hepatocellular carcinoma. J Clin Gastroenterol 45:e87\u2013e91","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl","key":"654_CR21","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/BF00686676","volume":"33","author":"S Watanabe","year":"1994","unstructured":"Watanabe S, Nishioka M, Ohta Y, Ogawa N, Ito S, Yamamoto Y (1994) Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area. Cancer Chemother Pharmacol 33(Suppl):S93\u2013S96","journal-title":"Cancer Chemother Pharmacol"},{"key":"654_CR22","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","volume":"23","author":"PM Lopez","year":"2006","unstructured":"Lopez PM, Villanueva A, Llovet JM (2006) Systematic review: evidence-based management of hepatocellular carcinoma\u2014an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23:1535\u20131547","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"654_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2036.17.s2.19.x","volume":"17","author":"JC Trinchet","year":"2003","unstructured":"Trinchet JC, Ganne-Carrie N, Beaugrand M (2003) Review article: intra-arterial treatments in patients with hepatocellular carcinoma. Aliment Pharmacol Ther 17(Suppl 2):111\u2013118","journal-title":"Aliment Pharmacol Ther"},{"key":"654_CR24","unstructured":"Common terminology criteria for adverse events v3.0 (CTCAE). http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm . Accessed 7 Apr 2012"},{"key":"654_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"654_CR26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"654_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0305-7372(02)00123-8","volume":"29","author":"M Varela","year":"2003","unstructured":"Varela M, Sala M, Llovet JM, Bruix J (2003) Treatment of hepatocellular carcinoma: is there an optimal strategy? Cancer Treat Rev 29:99\u2013104","journal-title":"Cancer Treat Rev"},{"key":"654_CR28","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.1994.12.6.1323","volume":"12","author":"AP Venook","year":"1994","unstructured":"Venook AP (1994) Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 12:1323\u20131334","journal-title":"J Clin Oncol"},{"key":"654_CR29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2036.2012.05072.x","volume":"35","author":"JR Maggs","year":"2012","unstructured":"Maggs JR, Suddle AR, Aluvihare V, Heneghan MA (2012) Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma. Aliment Pharmacol Ther 35:1113\u201311134","journal-title":"Aliment Pharmacol Ther"},{"key":"654_CR30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.gassur.2005.10.006","volume":"10","author":"JN Cormier","year":"2006","unstructured":"Cormier JN, Thomas KT, Chari RS, Pinson CW (2006) Management of hepatocellular carcinoma. J Gastrointest Surg 10:761\u2013780","journal-title":"J Gastrointest Surg"},{"issue":"Suppl 1","key":"654_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000333277","volume":"81","author":"JY Choi","year":"2011","unstructured":"Choi JY (2011) Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea. Oncology 81(Suppl 1):141\u2013147","journal-title":"Oncology"},{"issue":"Suppl 4","key":"654_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1634\/theoncologist.2010-S4-42","volume":"15","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Chen XP, Dagher L, Venook AP (2010) Treatment of intermediate\/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist 15(Suppl 4):42\u201352","journal-title":"Oncologist"},{"key":"654_CR33","first-page":"CD004787","volume":"3","author":"RS Oliveri","year":"2011","unstructured":"Oliveri RS, Wetterslev J, Gluud C (2011) Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Cochrane Database Syst Rev 3:CD004787","journal-title":"Cochrane Database Syst Rev"},{"key":"654_CR34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","volume":"12","author":"DA Leung","year":"2001","unstructured":"Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC (2001) Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 12:321\u2013326","journal-title":"J Vasc Interv Radiol"},{"key":"654_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","volume":"30","author":"L Marelli","year":"2007","unstructured":"Marelli L, Stigliano R, Triantos C et al (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6\u201325","journal-title":"Cardiovasc Intervent Radiol"},{"key":"654_CR36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","volume":"34","author":"H Malenstein van","year":"2011","unstructured":"van Malenstein H, Maleux G, Vandecaveye V et al (2011) A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma. Onkologie 34:368\u2013376","journal-title":"Onkologie"},{"key":"654_CR37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","volume":"101","author":"R Dhanasekaran","year":"2010","unstructured":"Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS (2010) Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC). J Surg Oncol 101:476\u2013480","journal-title":"J Surg Oncol"},{"key":"654_CR38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jvir.2009.10.038","volume":"21","author":"A Nicolini","year":"2010","unstructured":"Nicolini A, Martinetti L, Crespi S, Maggioni M, Sangiovanni A (2010) Transarterial chemoembolization with epirubicin-eluting beads versus transarterial embolization before liver transplantation for hepatocellular carcinoma. J Vasc Interv Radiol 21:327\u2013332","journal-title":"J Vasc Interv Radiol"},{"issue":"Suppl 3","key":"654_CR39","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1046\/j.1440-1746.17.s3.40.x","volume":"17","author":"JM Llovet","year":"2002","unstructured":"Llovet JM (2002) Evidence-based medicine in the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 17(Suppl 3):S428\u2013S433","journal-title":"J Gastroenterol Hepatol"},{"key":"654_CR40","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1200\/JCO.2011.37.1021","volume":"29","author":"TM Pawlik","year":"2011","unstructured":"Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF (2011) Phase II trial of Sorafenib combined with concurrent transarterial chemoembolization with drug eluting beads for hepatocellular carcinoma. J Clin Oncol 29:3960\u20133967","journal-title":"J Clin Oncol"},{"key":"654_CR41","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.24644","volume":"54","author":"M Iavarone","year":"2011","unstructured":"Iavarone M, Cabibbo G, Piscaglia F, Zavaglia C, Grieco A, Villa E, Camma C, Colombo M (2011) Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Hepatology 54:2055\u20132063","journal-title":"Hepatology"},{"key":"654_CR42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.12111550","volume":"263","author":"M Pinter","year":"2012","unstructured":"Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Konigberg R, Stauber R, Grunberger B, Muller C, Kolblinger C, Peck-Radosavljevic M, Sieghart W (2012) Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology 263:590\u2013599","journal-title":"Radiology"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-013-0654-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-013-0654-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-013-0654-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T03:48:05Z","timestamp":1595908085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-013-0654-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1007\/s00270-013-0654-7","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,12]]}}}